
Theodore S. Johnson, MD, PhD, discusses immune activation and survival with indoximod plus temozolomide in recurrent ependymoma.

Theodore S. Johnson, MD, PhD, is co-director of the Pediatric Immunotherapy Program and a professor of pediatric oncology at Augusta University and the Wellstar Health System.

Theodore S. Johnson, MD, PhD, discusses immune activation and survival with indoximod plus temozolomide in recurrent ependymoma.